Trial Profile
Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 18 Nov 2012
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Tegafur/uracil (Primary) ; Folinic acid
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms TEGAFOX
- 23 Jun 2011 New trial record